User:Mr. Ibrahem/Pimecrolimus
Clinical data | |
---|---|
Trade names | Elidel |
AHFS/Drugs.com | Monograph |
Pregnancy category |
|
Routes of administration | topical |
Drug class | Calcineurin inhibitor[1] |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | low systemic absorption |
Protein binding | 74%–87% |
Metabolism | Hepatic CYP3A |
Identifiers | |
| |
Chemical and physical data | |
Formula | C43H68ClNO11 |
Molar mass | 810.46 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Pimecrolimus, sold under the brand name Elidel, is a medication used to treat atopic dermatitis (eczema) and psoriasis.[1][2] It is a second line treatment after topical corticosteroids.[1] It is applied to the skin as a cream.[1]
Common side effects include skin reaction, headache, and cough.[1] Other concerns may include cancer and infections.[1] Use is not recommended in pregnancy.[2] It is a calcineurin inhibitor.[1]
was approved for medical use in the United States in 2001.[1] In the United Kingdom a 30 gram tube costs the NHS about £20 as of 2021.[2] This amount in the United States is about 70 USD.[3]
References[edit]
- ^ a b c d e f g h i j k "Pimecrolimus Monograph for Professionals". Drugs.com. Archived from the original on 8 October 2021. Retrieved 28 October 2021.
- ^ a b c d BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 1299. ISBN 978-0857114105.
- ^ "Pimecrolimus Prices and Pimecrolimus Coupons - GoodRx". GoodRx. Archived from the original on 8 May 2016. Retrieved 28 October 2021.